Whole Blood Opens New Route to Biomarker Discovery - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Whole Blood Opens New Route to Biomarker Discovery

  • September 4, 2026

  • 2 min

Share

Clinical Scorecard: Whole Blood Opens New Route to Biomarker Discovery

At a Glance

CategoryDetail
ConditionExtracellular Vesicles (EVs) Research
Key MechanismsProtein organic solvent precipitation (PROSPR) workflow for EV extraction
Target PopulationResearchers and laboratories involved in biomarker discovery
Care SettingLaboratory research

Key Highlights

  • Rapid extraction of EVs from whole blood using PROSPR method
  • Whole-blood EVs contain unique molecular information not captured by plasma EVs
  • Identified 251 proteins unique to blood-derived EVs
  • Method enriches EVs in less than 20 minutes
  • Potential for revisiting existing biobank samples for biomarker discovery

Guideline-Based Recommendations

Diagnosis

  • Further validation needed before clinical use of identified biomarkers

Management

  • Consider whole blood as a complementary source for EV biomarkers

Monitoring & Follow-up

  • Monitor for changes in molecular signals post-blood collection

Risks

  • Some signals may result from changes occurring after blood collection

Patient & Prescribing Data

Not specified; relevant for research cohorts

Potential for discovering diagnostic or prognostic markers

Clinical Best Practices

  • Utilize whole blood samples for EV research to broaden molecular information
  • Adhere to established purity criteria for EV preparations

Related Resources & Content

    Original Source(s)

    Related Content